Y. Ko

740 total citations
13 papers, 490 citations indexed

About

Y. Ko is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Y. Ko has authored 13 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Y. Ko's work include Epigenetics and DNA Methylation (3 papers), Glutathione Transferases and Polymorphisms (2 papers) and Brain Metastases and Treatment (2 papers). Y. Ko is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Glutathione Transferases and Polymorphisms (2 papers) and Brain Metastases and Treatment (2 papers). Y. Ko collaborates with scholars based in Germany, South Korea and Finland. Y. Ko's co-authors include Josef Abel, Volker Harth, Samer Ezziddin, U. Pöge, Α. Türler, H. Palmedo, H. J. Biersack, Hojjat Ahmadzadehfar, Christian Marx and Uwe-Jochen Göhring and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

Y. Ko

12 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Ko Germany 6 221 185 117 112 67 13 490
Cathy Fan United States 8 133 0.6× 143 0.8× 77 0.7× 29 0.3× 48 0.7× 20 482
Tomoyuki Aruga Japan 13 230 1.0× 132 0.7× 71 0.6× 33 0.3× 161 2.4× 59 403
Beata Herberger Austria 13 516 2.3× 224 1.2× 119 1.0× 65 0.6× 66 1.0× 19 810
S.-A. Im South Korea 12 478 2.2× 271 1.5× 93 0.8× 167 1.5× 159 2.4× 39 686
Aurélie Ferru France 11 250 1.1× 82 0.4× 93 0.8× 42 0.4× 86 1.3× 30 439
De-Bing Shi China 9 91 0.4× 58 0.3× 275 2.4× 62 0.6× 264 3.9× 9 473
Meiling Zhu China 14 137 0.6× 156 0.8× 199 1.7× 21 0.2× 92 1.4× 25 410
Nuria Rodrı́guez-Salas Spain 13 307 1.4× 99 0.5× 140 1.2× 15 0.1× 114 1.7× 32 485
Erion Dobi France 14 217 1.0× 147 0.8× 74 0.6× 22 0.2× 111 1.7× 31 356
Huiping Xue China 12 151 0.7× 101 0.5× 163 1.4× 22 0.2× 92 1.4× 16 503

Countries citing papers authored by Y. Ko

Since Specialization
Citations

This map shows the geographic impact of Y. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Ko more than expected).

Fields of papers citing papers by Y. Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Ko. The network helps show where Y. Ko may publish in the future.

Co-authorship network of co-authors of Y. Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Ko. A scholar is included among the top collaborators of Y. Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Ko. Y. Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Kim, So Young, June‐Young Koh, Dong Hyeon Lee, et al.. (2024). Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals. Journal of Hepatology. 81(5). 806–818. 3 indexed citations
3.
4.
Eisert, Anna, Matthias Scheffler, Sebastian Michels, et al.. (2014). Genetic Variability and Clinical Presentation of Patients with Non-Small Cell Lung Cancer (Nsclc) Harboring Met-Amplifications. Annals of Oncology. 25. iv463–iv463. 1 indexed citations
5.
Palmedo, H., Christian Marx, Andreas D. Ebert, et al.. (2013). Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. European Journal of Nuclear Medicine and Molecular Imaging. 41(1). 59–67. 137 indexed citations
6.
Rabstein, Sylvia, Volker Harth, Beate Pesch, et al.. (2013). 99 Associations of polymorphisms in circadian genes, shift work and breast cancer in the German GENICA study. Occupational and Environmental Medicine. 70(Suppl 1). A33.2–A33. 1 indexed citations
7.
Neuhaus, T., Y. Ko, R.-P. Müller, et al.. (2009). A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. British Journal of Cancer. 100(2). 291–297. 71 indexed citations
8.
Olson, James E., Jian Zhang, Michelle A.T. Hildebrandt, et al.. (2008). Presidential Trainee Awards (PT 1-19)Displayed 6:00 pm. Clinical Pharmacology & Therapeutics. 83. S1–S8. 1 indexed citations
9.
10.
Ko, Y., T. Neuhaus, Gerhard G. Grabenbauer, et al.. (2007). A phase III trial of topotecan and whole brain radiation (WBRT) therapy for patients with CNS metastases due to lung cancer. Journal of Clinical Oncology. 25(18_suppl). 2049–2049. 1 indexed citations
11.
Josting, Andreas, Michal Sieniawski, Oliver Staak, et al.. (2005). High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study. Annals of Oncology. 16(8). 1359–1365. 48 indexed citations
12.
Abel, Josef, Y. Ko, Volker Harth, et al.. (2003). Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. British Journal of Cancer. 88(5). 675–678. 66 indexed citations
13.
Ko, Y., Josef Abel, Volker Harth, et al.. (2001). Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.. PubMed. 61(11). 4398–404. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathy Fan Breakdown of academic impact, for papers by Tomoyuki Aruga Breakdown of academic impact, for papers by Beata Herberger Breakdown of academic impact, for papers by S.-A. Im Breakdown of academic impact, for papers by Aurélie Ferru Breakdown of academic impact, for papers by De-Bing Shi Breakdown of academic impact, for papers by Meiling Zhu Breakdown of academic impact, for papers by Nuria Rodrı́guez-Salas Breakdown of academic impact, for papers by Erion Dobi Breakdown of academic impact, for papers by Huiping Xue
Rankless by CCL
2026